Szymon Janczar
Biographic Data
| ID | 8252621 |
|---|---|
| NAME | Szymon Janczar |
| GIVEN NAMES | Szymon |
| FAMILY NAME | Janczar |
| SIGNATURE | JANCZAR S |
| AFFILIATIONS | Medical University of Lodz |
| ORCID | 0000-0001-8007-6969 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Venetoclax Use in Paediatric Haemato-Oncology Centres in Poland
Venetoclax, the best established BH3-mimetic, is a practice-changing proapoptotic drug in blood cancers in adults. In paediatrics the data are fewer but exciting results were recently presented in relapsed or refractory leukaemias demonstrating significant clinical activity. Importantly, the in-terventions could be potentially molecularly guided as vulnerabilities to BH3-mimetics were re-ported. Currently venetoclax is not incorporated into paedi…
Pulmonary Exacerbation of Undiagnosed Toxocariasis in Intensively-Treated High-Risk Neuroblastoma Patients
Toxocariasis is one of the most common zoonoses, with high seroprevalence in apparently healthy individuals. Neuroblastoma is an aggressive childhood cancer. The cure rates are improving due to dose-dense chemotherapy, progress in surgical practice, myeloablative therapy with autologous stem cell transplantation, and recently, anti-GD2 immunotherapy. This is associated with a burden of complications, some of which are relatively specific for neur…
No prominent works on this page.
Pulmonary Exacerbation of Undiagnosed Toxocariasis in Intensively-Treated High-Risk Neuroblastoma Patients
Toxocariasis is one of the most common zoonoses, with high seroprevalence in apparently healthy individuals. Neuroblastoma is an aggressive childhood cancer. The cure rates are improving due to dose-dense chemotherapy, progress in surgical practice, myeloablative therapy with autologous stem cell transplantation, and recently, anti-GD2 immunotherapy. This is associated with a burden of complications, some of which are relatively specific for neur…
Venetoclax Use in Paediatric Haemato-Oncology Centres in Poland
Venetoclax, the best established BH3-mimetic, is a practice-changing proapoptotic drug in blood cancers in adults. In paediatrics the data are fewer but exciting results were recently presented in relapsed or refractory leukaemias demonstrating significant clinical activity. Importantly, the in-terventions could be potentially molecularly guided as vulnerabilities to BH3-mimetics were re-ported. Currently venetoclax is not incorporated into paedi…
Internal Medicine (2 works) · Medicine (2 works) · Pediatrics (2 works) · Acute Lymphoblastic Leukemia research (1 work) · Acute Myeloid Leukemia Research (1 work) · Amoebic Infections and Treatments (1 work) · Cancer (1 work) · Chemotherapy (1 work) · Chronic Lymphocytic Leukemia Research (1 work) · Complication (1 work)